KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
DMA 100DMA 200DMA 50Dividend YieldEV to CFOEV to EBITEV to EBITDAEV to FCFEV to RevenueEnterprise ValueMarket Cap to FCFMarket CapitalizationPricePrice to EarningsPrice to Sales
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Cvs Health (CVS) Enterprise Value (2016 - 2025)

Cvs Health's Enterprise Value history spans 17 years, with the latest figure at -$10.4 billion for Q4 2025.

  • For the quarter ending Q4 2025, Enterprise Value rose 3.63% year-over-year to -$10.4 billion, compared with a TTM value of -$10.4 billion through Dec 2025, up 3.63%, and an annual FY2025 reading of -$10.4 billion, up 3.63% over the prior year.
  • Enterprise Value for Q4 2025 was -$10.4 billion at Cvs Health, up from -$11.0 billion in the prior quarter.
  • The five-year high for Enterprise Value was -$8.5 billion in Q1 2021, with the low at -$19.7 billion in Q3 2022.
  • Average Enterprise Value over 5 years is -$13.1 billion, with a median of -$12.5 billion recorded in 2021.
  • Year-over-year, Enterprise Value soared 42.77% in 2021 and then plummeted 58.83% in 2023.
  • Tracing CVS's Enterprise Value over 5 years: stood at -$12.2 billion in 2021, then decreased by 26.22% to -$15.4 billion in 2022, then rose by 26.86% to -$11.3 billion in 2023, then grew by 4.05% to -$10.8 billion in 2024, then grew by 3.63% to -$10.4 billion in 2025.
  • Per Business Quant, the three most recent readings for CVS's Enterprise Value are -$10.4 billion (Q4 2025), -$11.0 billion (Q3 2025), and -$14.0 billion (Q2 2025).